The short version of thymosin beta-4 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-24 and is reviewed periodically as new material appears.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (dry) | -20 °C | Protected from light and moisture |
| Storage temperature (solution) | -80 °C | Single-use aliquots recommended |
| Identity assay | LC-MS or MALDI-TOF | Confirms mass near 889 Da |
| Purity assay | RP-HPLC | Reports main peak percentage |
| Common impurities | Truncated peptides, deamidated forms | Arise from synthesis or storage |
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Poole integrates into the society of 3001, but is prompted by a friend to revisit Europa, a cradle of nascent life from which the monolith had banned humanity almost a millennium earlier. It is believed he might be the first person allowed to visit there. On Europa he is greeted by the voice of David Bowman and computer HAL 9000, who have now become a single entity—Halman—residing as digitized lifeforms in the monolith's computational matrix. In subsequent conversations he learns that the monoliths themselves are mechanisms, answerable to an unknown superior monolith, or perhaps lifeforms, almost 450 light-years away. Thirty years later, Poole is married, and a member of a small team responsible for monitoring Europa. Halman contacts him to warn that following the events of 2010: Odyssey Two and 2061: Odyssey Three, the Jovian monolith had sent a report to its superior monolith, containing details about the human species after first contact. Since this report took place shortly after the wars of the 20th century, Halman believes the response just received after the 900-year round trip contains instructions to destroy humanity, due to its perceived failure as a species. Unsure whether they can physically harm the Monolith, the Europa team decide instead to infect it—as a computational mechanism—with a computer virus. Poole requests Halman to act as a Trojan Horse and place the virus inside the monolith, where it will be executed.
===== MeSH D08.811.277.040 – acid anhydride hydrolases (EC 3.6) ===== MeSH D08.811.277.040.025 – adenosinetriphosphatase MeSH D08.811.277.040.025.095 – ca(2+) mg(2+)-atpase MeSH D08.811.277.040.025.125 – ca(2+)-transporting atpase MeSH D08.811.277.040.025.150 – dynein atpase MeSH D08.811.277.040.025.237 – muts dna mismatch-binding protein MeSH D08.811.277.040.025.281 – muts homolog 2 protein MeSH D08.811.277.040.025.303 – n-ethylmaleimide-sensitive proteins MeSH D08.811.277.040.025.325 – proton-translocating atpases MeSH D08.811.277.040.025.325.249 – bacterial proton-translocating atpases MeSH D08.811.277.040.025.325.500 – chloroplast proton-translocating atpases MeSH D08.811.277.040.025.325.625 – h(+)-k(+)-exchanging atpase MeSH D08.811.277.040.025.325.750 – mitochondrial proton-translocating atpases MeSH D08.811.277.040.025.325.875 – vacuolar proton-translocating atpases MeSH D08.811.277.040.025.450 – kinesin MeSH D08.811.277.040.025.525 – myosins MeSH D08.811.277.040.025.525.500 – myosin type i MeSH D08.811.277.040.025.525.750 – myosin type ii MeSH D08.811.277.040.025.525.750.124 – cardiac myosins MeSH D08.811.277.040.025.525.750.124.249 – atrial myosins MeSH D08.811.277.040.025.525.750.124.500 – ventricular myosins MeSH D08.811.277.040.025.525.750.374 – nonmuscle myosin type iia MeSH D08.811.277.040.025.525.750.500 – nonmuscle myosin type iib MeSH D08.811.277.040.025.525.750.750 – skeletal muscle myosins MeSH D08.811.277.040.025.525.750.875 – smooth muscle myosins MeSH D08.811.277.040.025.525.812 – myosin type iii MeSH D08.811.277.040.025.525.843 – myosin type iv MeSH D08.811.277.040.025.525.875 – myosin type v MeSH D08.811.277.040.025.600 – na(+)-k(+)-exchanging atpase MeSH D08.811.277.040.050 – apyrase MeSH D08.811.277.040.330 – gtp phosphohydrolases MeSH D08.811.277.040.330.200 – dynamins MeSH D08.811.277.040.330.200.100 – dynamin i MeSH D08.811.277.040.330.200.200 – dynamin ii MeSH D08.811.277.040.330.200.300 – dynamin iii MeSH D08.811.277.040.330.300 – gtp-binding proteins MeSH D08.811.277.040.330.300.100 – gtp phosphohydrolase-linked elongation factors MeSH D08.811.277.040.330.300.100.200 – peptide elongation factor g MeSH D08.811.277.040.330.300.100.700 – peptide elongation factor tu MeSH D08.811.277.040.330.300.100.800 – peptide elongation factor 1 MeSH D08.811.277.040.330.300.100.850 – peptide elongation factor 2 MeSH D08.811.277.040.330.300.200 – heterotrimeric gtp-binding proteins MeSH D08.811.277.040.330.300.200.100 – gtp-binding protein alpha subunits MeSH D08.811.277.040.330.300.200.100.100 – gtp-binding protein alpha subunits, g12-g13 MeSH D08.811.277.040.330.300.200.100.200 – gtp-binding protein alpha subunits, gi-go MeSH D08.811.277.040.330.300.200.100.200.500 – gtp-binding protein alpha subunit, gi2 MeSH D08.811.277.040.330.300.200.100.300 – gtp-binding protein alpha subunits, gq-g11 MeSH D08.811.277.040.330.300.200.100.400 – gtp-binding protein alpha subunits, gs MeSH D08.811.277.040.330.300.200.800 – transducin MeSH D08.811.277.040.330.300.400 – monomeric gtp-binding proteins MeSH D08.811.277.040.330.300.400.100 – adp-ribosylation factors MeSH D08.811.277.040.330.300.400.100.100 – ADP-ribosylation factor 1 MeSH D08.811.277.040.330.300.400.400 – rab gtp-binding proteins MeSH D08.811.277.040.330.300.400.400.025 – rab1 gtp-binding proteins MeSH D08.811.277.040.330.300.400.400.050 – rab2 gtp-binding protein MeSH D08.811.277.040.330.300.400.400.100 – rab3 gtp-binding proteins MeSH D08.811.277.040.330.300.400.400.100.500 – rab3a gtp-binding protein MeSH D08.811.277.040.330.300.400.400.150 – rab4 gtp-binding proteins MeSH D08.811.277.040.330.300.400.400.200 – rab5 gtp-binding proteins MeSH D08.811.277.040.330.300.400.450 – ral gtp-binding proteins MeSH D08.811.277.040.330.300.400.462 – ran gtp-binding protein MeSH D08.811.277.040.330.300.400.475 – rap gtp-binding proteins MeSH D08.811.277.040.330.300.400.475.100 – rap1 gtp-binding proteins MeSH D08.811.277.040.330.300.400.500 – ras proteins MeSH D08.811.277.040.330.300.400.500.300 – oncogene protein p21(ras) MeSH D08.811.277.040.330.300.400.500.600 – proto-oncogene proteins p21(ras) MeSH D08.811.277.040.330.300.400.700 – rho gtp-binding proteins MeSH D08.811.277.040.330.300.400.700.050 – cdc42 gtp-binding protein MeSH D08.811.277.040.330.300.400.700.060 – cdc42 gtp-binding protein, saccharomyces cerevisiae MeSH D08.811.277.040.330.300.400.700.100 – rac gtp-binding proteins MeSH D08.811.277.040.330.300.400.700.100.500 – rac1 gtp-binding protein MeSH D08.811.277.040.330.300.400.700.200 – rhoa gtp-binding protein MeSH D08.811.277.040.330.300.400.700.300 – rhob gtp-binding protein MeSH D08.811.277.040.465 – nucleoside-triphosphatase MeSH D08.811.277.040.600 – pyrophosphatases MeSH D08.811.277.040.600.399 – inorganic pyrophosphatase MeSH D08.811.277.040.600.800 – thiamine pyrophosphatase MeSH D08.811.277.040.850 – thiamin-triphosphatase
== Resonance assignment == In order to analyze the nuclear magnetic resonance data, it is important to get a resonance assignment for the protein, that is to find out which chemical shift corresponds to which atom. This is typically achieved by sequential walking using information derived from several different types of NMR experiment. The exact procedure depends on whether the protein is isotopically labelled or not, since a lot of the assignment experiments depend on carbon-13 and nitrogen-15.
The low energy consumption, low maintenance and small size of LEDs has led to uses as status indicators and displays on a variety of equipment and installations. Large-area LED displays are used as stadium displays, dynamic decorative displays, and dynamic message signs on freeways. Thin, lightweight message displays are used at airports and railway stations, and as destination displays for trains, buses, trams, and ferries.
Sources: en.wikipedia.org
== Operations == JEOL Ltd. has four business segments. Electron Optics manufactures scanning electron microscopes, transmission electron microscopes and scanning probe microscopes, along with related equipment. The Analytical Instruments section's products include mass spectrometers, nuclear magnetic resonance and electron spin resonance equipment. The Industrial Equipment segment covers a range of equipment particularly targeted at the semiconductor industry, such as electron beam sources, wafer process monitors, and plasma gun series. Finally, the Medical Equipment segment manufactures automatic analysis devices, clinical diagnostic systems and amino acid analyzers.
Similarly to the SIR model, also, in this case, we have a Disease-Free-Equilibrium (N,0,0,0) and an Endemic Equilibrium EE, and one can show that, independently from biologically meaningful initial conditions
Moreover, Esimone's research team was the first to demonstrate the occurrence of the FOX-1 gene, responsible for expressing the AmpC enzyme in gram-negative bacteria in Nigeria. This enzyme significantly enhances the ability of organisms to resist cephamycin antibiotics.
In the late 2000s, the Cherngs began implementing play areas, known as the Panda Express Play Places, which had been developed in the late 90's by their business partner, Reginald Schwaab. The Play Places were a major success, primarily on the East Coast of America, where the chain continued to succeed. Due to COVID and increased costs regarding upkeep, the play places were removed from the chain in August 2020.
Biotechnology is the application of scientific and engineering principles to the processing of materials by biological agents in order to provide goods and services. From its inception, biotechnology has maintained a close relationship with society. Although now most often associated with the development of drugs, historically biotechnology has been principally associated with food, addressing such issues as malnutrition and famine. The history of biotechnology begins with zymotechnology, which commenced with a focus on brewing techniques for beer. By World War I, however, zymotechnology would expand to tackle larger industrial issues, and the potential of industrial fermentation gave rise to biotechnology. However, both the single-cell protein and gasohol projects failed to progress due to varying issues including public resistance, a changing economic scene, and shifts in political power. Yet the formation of a new field, genetic engineering, would soon bring biotechnology to the forefront of science in society, and the intimate relationship between the scientific community, the public, and the government would ensue. These debates gained exposure in 1975 at the Asilomar Conference, where Joshua Lederberg was the most outspoken supporter for this emerging field in biotechnology. By as early as 1978, with the development of synthetic human insulin, Lederberg's claims would prove valid, and the biotechnology industry grew rapidly.
Sources: en.wikipedia.org
A 2008 study of radiation from post-mastectomy radiotherapy showed that the simple models previously used to assess the combined and separate risks from radiation and smoking were in need of development. The frequently used linear no-threshold model that describes how the body responds to and is damaged by radiation is one of these models.
Stimulants such as epinephrine, theophylline, and salbutamol orally have been used to treat asthma, but inhaled adrenergic drugs are now preferred due to less systemic side effects. Pseudoephedrine is used to relieve nasal or sinus congestion caused by the common cold, sinusitis, allergic rhinitis, and other respiratory allergies; it is also used to relieve ear congestion caused by ear inflammation or infection.
Lysergic acid, or lysergate, also known as D-lysergic acid and (+)-lysergic acid, is a precursor for a wide range of ergoline alkaloids that are produced by the ergot fungus and found in the seeds of Argyreia nervosa (Hawaiian baby woodrose), and Ipomoea species (morning glories, ololiuhqui, tlitliltzin). Amides of lysergic acid, lysergamides, are widely used as pharmaceuticals and as psychedelic drugs, e.g. lysergic acid diethylamide (LSD). Lysergic acid is listed as a Table I precursor under the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. The name "lysergic acid" comes from the fact that it is a carboxylic acid, and it was first made by hydrolysis of various ergot alkaloids.
The formation of a complex between a metal ion, M, and a ligand, L, is in fact usually a substitution reaction. For example, In aqueous solutions, metal ions will be present as aquo ions, so the reaction for the formation of the first complex could be written as
Calcitriol exerts its effects primarily by binding to the vitamin D receptor (VDR), which leads to the upregulation of gene transcription. In the absence of calcitriol, the VDR is mainly located in the cytoplasm of cells. Calcitriol enters cells and binds to the VDR which forms a complex with its coreceptor RXR and the activated VDR/RXR complex is translocated into the nucleus. The VDR/RXR complex subsequently binds to vitamin D response elements (VDRE) which are specific DNA sequences adjacent to genes, numbers estimated as being in the thousands. The VDR/RXR/DNA complex recruits other proteins that transcribe the downstream gene into mRNA which in turn is translated into protein causing a change in cell function. In addition to calcitriol, other vitamin D metabolites may contribute to vitamin D's biological effects. For example, CYP11A1, an enzyme chiefly known for its role in steroidogenesis, has been found to hydroxylate vitamin D3 at several positions, including C-20, C-22, and C-23, without cleaving the side chain. The resulting metabolites, such as 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3, act as inverse agonists for RORα and RORγ2. This interaction leads to effects such as the downregulation of IL-17 signaling, which influences the immune system. Finally, some effects of vitamin D occur too rapidly to be explained by its influence on gene transcription. For example, calcitriol triggers rapid calcium uptake (within 1–10 minutes) in a variety of cells. These non-genomic actions may involve membrane-bound receptors like PDIA3.
Sources: en.wikipedia.org
The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.
Reverse-phase HPLC assesses purity, and mass spectrometry confirms molecular mass. The combination helps distinguish the target peptide from truncated or modified impurities.
Buffer composition, pH, adsorption to containers, and freeze-thaw history can all affect the amount of intact peptide in solution. These factors may change results even when the starting material is chemically correct.
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.